kentucky glp-1 gastric stasis legal team attorney J. Stan Lee — Sturgill Turner The Fat-Pancreas Axis: A Narrative

Description

Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which typically diminish over time

Patients initiating GLP-1 RA treatment (semaglutide, liraglutide, tirzepatide) were propensity scorematched (1:1) with RA controls not receiving GLP-1 RA therapy, balancing demographics, BMI categories, cardiovascular comorbidities, immunosuppressive therapies, and cardiometabolic medications

Key points: All medications have possible side effects, especially if you have other health conditions

weight loss tends to start gradually and builds with consistency

Why This Study Is Not the Final Word The UTMB study is important because it offers the first large real-world data linking semaglutide with increased risk of ED and low testosterone